Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
06/2002
06/04/2002CA2302396C Allosteric adenosine receptor modulators
06/04/2002CA2029497C 4-acylaminopyridine derivative
05/2002
05/30/2002WO2002042427A2 Mass tags for quantitative analysis
05/30/2002WO2002042311A2 Biotin derivatives, methods for making same and uses thereof as vectors
05/30/2002WO2002041896A2 Use of thienopyrimidines
05/30/2002WO2002004444A3 Heterocycle carboxamides as antiviral agents
05/30/2002WO2001085686A3 Multicyclic compounds and the use as inhibitors of parp, vegfr2 and mlk3 enzymes
05/30/2002WO2001021160B1 Carboxymide and aniline derivatives as selective inhibitors of pathogens
05/30/2002US20020065272 Olanzapine-N-oxide compositions and methods
05/30/2002US20020065268 New compounds, their preparation and use
05/30/2002US20020065267 Compounds, their preparation and use
05/30/2002US20020064799 Proteomic analysis
05/30/2002CA2429647A1 Use of thienopyrimidines
05/29/2002EP1208097A2 Substituted oxoazaheterocyclyl compounds
05/29/2002EP1117656B1 Grey colouring photochromic fused pyrans
05/29/2002DE10058663A1 Verwendung von Thienopyrimidinen Use of Thienopyrimidinen
05/29/2002CN1351604A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
05/29/2002CN1351581A Novel carboxylic acid derivatives and process for producing the same
05/29/2002CN1134400C Novel carboxylic acid derivatives and process for producing the same
05/28/2002US6395749 Carboxamide compounds, methods, and compositions for inhibiting PARP activity
05/28/2002CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them
05/23/2002WO2002040482A1 Process for producing carbapenem-type antibacterial
05/23/2002WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002WO2002040455A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/23/2002WO2001074348A8 Vasopeptidase inhibitors to treat isolated systolic hypertension
05/23/2002US20020061880 New compounds, their preparation and use
05/23/2002US20020061876 Compounds, their preparation and use
05/23/2002US20020059684 Including coumarins, rhodamines, and rhodols that incorporate additional fused aromatic rings; absorb at a longer wavelength than structurally similar dyes that do not possess the fused aromatic rings; dye conjugates; reactive dyes
05/23/2002CA2429071A1 Processes for the preparation of carbapenem-type antibacterial agents
05/23/2002CA2428844A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
05/23/2002CA2428335A1 Substituted amidoalkyl uracils and their use as inhibitors of the poly(adp-ribose) synthetase (pars)
05/22/2002EP1206473A1 Isomeric fused pyrrolocarbazoles and isoindolones
05/22/2002EP1206452A2 Novel method for preparing benzoperhydroisoindole compounds
05/22/2002CN1350458A Protease inhibitors
05/21/2002US6391912 Pesticides, herbicides
05/21/2002US6391905 4,5-dihydro-8-methylthio-2-phenylfuro(3,4-e)benzothiazole-6-ca rboxylic acid, for example; anti-matrix metalloprotease activity; for bone diseases such as osteoporosis, rheumatoid arthritis, cancer metastasis
05/16/2002WO2002038563A2 Condensed pyrazindione derivatives as pde inhibitors
05/16/2002WO2002038559A1 1,3-diazaheterocyclic compounds and their use as oral hypoglycaemic agents
05/16/2002WO2002038540A2 Activity-dependent cysteine protease profiling reagent
05/16/2002WO2001098290A3 Thiophene derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/16/2002WO2001087038A3 β-CARBOLINE DERIVATIVES USEFUL AS INHIBITORS OF PHOSPHODIESTERASE
05/16/2002WO2001062946A8 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
05/16/2002US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives
05/16/2002US20020058155 Cyclic tertiary amine compound and organic electroluminescent device containing the compound
05/16/2002DE10056312A1 New 1-(N-substituted amidoalkyl) bicyclic uracil derivatives useful as medicaments for treating ischemia or reperfusion damage, are poly-(ADP-ribose)-synthetase inhibitors
05/15/2002EP1204665A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof
05/15/2002EP1204643A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
05/15/2002EP1204640A2 Chemokine receptor antagonists and methods of use therefor
05/15/2002EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
05/15/2002CN1349538A Cyclocarbamate and cyclic amide derivatives
05/15/2002CN1349536A Thienopyrimidine compounds, their production and use
05/15/2002CN1349535A Bicyclic heteroaromatic compounds useful as LH agonists
05/15/2002CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents
05/15/2002CN1084741C Novel benzothiepines having activities as inhibitors of ileal bile acid transport and taurocholate uptake
05/14/2002US6387942 Pyrazolyl compound; anticoagulants, antiproliferative agent
05/14/2002US6387924 Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
05/14/2002US6387912 Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
05/14/2002US6387909 Vision defects; benign prostatic hyperplasia
05/14/2002US6387893 Adrenergic blocking agent; benign prosatatic hyperplasia
05/14/2002US6387512 For coloring inks, fuels, plastics or glass
05/10/2002WO2002036599A1 Thieno[2,3-c]isoquinolines for use as inhibitors of parp
05/10/2002WO2002036583A1 Pgd2 receptor antagonistic pharmaceutical compositions
05/10/2002WO2001023389A3 Certain alkylene diamine-substituted heterocycles
05/09/2002US20020055507 Ureas and thioureas inhibit production of cytokines
05/09/2002US20020055502 New compounds, their preparation and use
05/09/2002US20020055094 Method of detection of influenza virus and compounds for use therein
05/09/2002US20020055039 Electrochemical utilization efficiency and capacity characteristics but also high reversibility of the charging/ discharging reaction
05/08/2002EP1202994A1 New compounds
05/08/2002EP1202988A2 Novel integrin receptor antagonists
05/08/2002EP1202985A2 Chemokine receptor antagonists
05/08/2002EP1202965A1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application
05/08/2002EP1202964A1 Condensed indoline derivatives and their use as 5ht, in particular 5ht2c, receptor ligands
05/08/2002EP1202729A1 Phosphate transport inhibitors
05/08/2002CN1348459A Heterocyclic metallocene compounds and use thereof in catalyst systems for producing olefin polymers
05/08/2002CN1347881A 法呢基蛋白转移酶抑制剂 Farnesyl protein transferase inhibitor
05/07/2002US6384040 Exhibit useful biological properties for controlling phytopathogenic microbicides.
05/07/2002US6383528 Antithrombotic preparation to suppress neutropenia, agranulocytosis, ischemia, and other side effects from the use of ticlopidine alone;
05/02/2002WO2002042244A2 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002WO2002034716A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/02/2002WO2002014324A3 Diazepinones as antiviral agents
05/02/2002WO2001048039A3 Process for the preparation of ethylene polymers
05/02/2002WO2001023375A3 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
05/02/2002US20020052512 Diaminopropionic acid derivatives
05/02/2002US20020052362 CRF receptor antagonists; treatment of endocrine, psychiatric and neurologic conditions or illnesses, including stress-related disorders
05/02/2002EP1201667A1 Polymerizable biotin derivatives, biotin polymer, and polymer responsive to avidin stimulation
05/02/2002EP1200446A1 OXATHIEPINO 6,5- i b /i ]DIHYDROPYRIDINES, AND RELATED COMPOSITIONS AND METHODS
05/02/2002EP1200445A1 Thienopyranecarboxamide derivatives
05/02/2002EP0888359B1 Pyrimidin-4-one derivatives as pesticide
05/02/2002CA2427473A1 Synthesis of chiral intermediates useful in preparing pharmacologically active compounds
05/02/2002CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity
05/01/2002CN1347417A 4-oxo-4,7-dihydro-thieno [2,3-b] pyridine-5-carboxamides as antiviral agent
04/2002
04/30/2002USRE37686 Biosynthesis of polypeptides
04/30/2002US6380395 Anticancer agents
04/30/2002US6380246 For combating pests and weeds
04/30/2002US6380211 For treating diabetes
04/30/2002US6380209 Highly selective agonists, antagonists or inverse agonists for gaba brain receptors or prodrugs, useful in the diagnosis and treatment of anxiety, down syndrome, sleep, cognitive and seizure disorders
04/25/2002WO2002032891A1 Flavan compounds, their preparation and their use in therapy
04/25/2002WO2002032872A1 Nitrogenous aromatic ring compounds
04/25/2002WO2001083440A3 Synthesis and use of thienotriazolodiazepines